Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, Phoenix A. Ho, Rong Zeng, Yaddanapudi Ravindranath, Gary Dahl, Norman J. Lacayo, David Becton, Myron Chang, Howard J. Weinstein, Betsy Hirsch, Susana C. Raimondi, Nyla A. Heerema, William G. Woods, Beverly J. Lange, Craig Hurwitz, Robert J. Arceci, Jerald P. Radich, Irwin D. BernsteinMichael C. Heinrich, Soheil Meshinchi

Research output: Contribution to journal › Article › peer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds